AAAAAA
Results:
1-8
|
Results: 8
Authors:
KUCERA LS
IYER N
MORRISNATSCHKE SL
CHEN SY
GUMUS F
ISHAQ K
HERRMANN DBJ
Citation: Ls. Kucera et al., IN-VITRO EVALUATION AND CHARACTERIZATION OF NEWLY DESIGNED ALKYLAMIDOPHOSPHOLIPID ANALOGS AS ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AGENTS, Antiviral chemistry & chemotherapy, 9(2), 1998, pp. 157-165
Authors:
MENSCHIK V
CORVINUS C
OPITZ HG
HERRMANN DBJ
Citation: V. Menschik et al., IN-VITRO ANTITUMOR-ACTIVITY AND INTRACELLULAR METABOLISM OF THE NEW CYTOSTATIC CYTOTOXIC COMPOUND BM 92.0700/, Naunyn-Schmiedeberg's archives of pharmacology, 356(4), 1997, pp. 64-64
Authors:
HERRMANN DBJ
OPITZ HG
KUCERA LS
Citation: Dbj. Herrmann et al., IN-VITRO AND IN-VIVO EVALUATION OF THE NEW ANTI-AIDS COMPOUND FOZIVUDINE, Naunyn-Schmiedeberg's archives of pharmacology, 356(4), 1997, pp. 174-174
Authors:
HERRMANN DBJ
MENSCHIK V
OPITZ HG
Citation: Dbj. Herrmann et al., INTRACELLULAR METABOLISM OF THE NEW ANTI-AIDS COMPOUND FOZIVUDINE IN ISOLATED HUMAN PERIPHERAL-BLOOD LEUKOCYTES, Naunyn-Schmiedeberg's archives of pharmacology, 356(4), 1997, pp. 175-175
Authors:
HOFMANN J
UTZ I
SPITALER M
HOFER S
RYBCZYNSKA M
BECK WT
HERRMANN DBJ
GRUNICKE H
Citation: J. Hofmann et al., RESISTANCE TO THE NEW ANTICANCER PHOSPHOLIPID ILMOFOSINE (BM-41,440), British Journal of Cancer, 76(7), 1997, pp. 862-869
Authors:
BOGNER JR
ROCKEN M
BOERNER D
JOST V
THOMAGREBER E
HERRMANN DBJ
HOEGL L
PLEWIG G
GOEBEL FD
Citation: Jr. Bogner et al., PHASE-I TRIAL WITH FOZIVUDINE TIDOXIL (BM-21.1290) - A CANDIDATE COMPOUND FOR FUTURE COMBINATION THERAPIES, AIDS, 10, 1996, pp. 20-20
Authors:
HERRMANN DBJ
OPITZ HG
Citation: Dbj. Herrmann et Hg. Opitz, BM-21.1290 - PHARMACOLOGICAL TOXICOLOGICAL EVALUATION OF A NOVEL CANDIDATE ANTI-AIDS DRUG, AIDS, 10, 1996, pp. 83-83
Authors:
CROFT SL
NEAL RA
THORNTON EA
HERRMANN DBJ
Citation: Sl. Croft et al., ANTILEISHMANIAL ACTIVITY OF THE ETHER PHOSPHOLIPID ILMOFOSINE, Transactions of the Royal Society of Tropical Medicine and Hygiene, 87(2), 1993, pp. 217-219
Risultati:
1-8
|